Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hazel Xiaohui Ang
Observed names:
Hazel Ang,
Hazel X. Ang
Institution:
Karolinska Institutet
Observed institutions:
Agency for Science, Technology and Research,
Duke University,
Karolinska Institutet,
Duke Medical Center,
Duke Cancer Institute,
Genome Institute of Singapore
show all 6
ORCID:
0000-0002-4194-7204
Observed ORCID:
0000-0002-4194-7204
OpenAlex ID:
A5073973941
Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells
2022
·
Moiez Ali
, Min Lu
, et al.
·
Science Translational Medicine
·
52
P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia
2022
·
Kevin H. Lin
, Justine C. Rutter
, et al.
·
Nature Cancer
·
49
Targeting a lineage-specific PI3Kɣ–Akt signaling module in acute myeloid leukemia using a heterobifunctional degrader molecule
2024
·
Lois M. Kelly
, Justine C. Rutter
, et al.
·
Nature Cancer
·
41
PDF
Pharmacogenomics in Asia: A Systematic Review on Current Trends and Novel Discoveries
2017
·
Hazel Xiaohui Ang
, Sze Ling Chan
, et al.
·
Pharmacogenomics
·
26
Cooperative regulation of coupled oncoprotein synthesis and stability in triple-negative breast cancer by EGFR and CDK12/13
2023
·
Hazel X. Ang
, Natalia Sutiman
, et al.
·
Proceedings of the National Academy of Sciences
·
19
PDF
CBF-Beta Mitigates PI3K-Alpha–Specific Inhibitor Killing through PIM1 in PIK3CA -Mutant Gastric Cancer
2023
·
Lyla J. Stanland
, Hazel X. Ang
, et al.
·
Molecular Cancer Research
·
16
PDF
Pasta, a Versatile Transcriptomic Clock, Maps the Chemical and Genetic Determinants of Aging and Rejuvenation
2026
·
Jérôme Salignon
, Maria Tsiokou
, et al.
·
Advanced Science
·
4
PDF
A versatile method for the identification of senolytic compounds
2023
·
Chiara Annunziata
, Francesca Castoldi
, et al.
·
Cell Stress
·
4
Data from CBF-Beta Mitigates PI3K-Alpha–Specific Inhibitor Killing through PIM1 in PIK3CA-Mutant Gastric Cancer
2023
·
Lyla J. Stanland
, Hazel X. Ang
, et al.
·
1
Figure S7 from CBF-beta mitigates PI3K-alpha-specific inhibitor killing through PIM1 in PIK3CA mutant gastric cancer
2024
·
Lyla J. Stanland
, Hazel X. Ang
, et al.
Figure S6 from CBF-beta mitigates PI3K-alpha-specific inhibitor killing through PIM1 in PIK3CA mutant gastric cancer
2024
·
Lyla J. Stanland
, Hazel X. Ang
, et al.
Table S6 from CBF-beta mitigates PI3K-alpha-specific inhibitor killing through PIM1 in PIK3CA mutant gastric cancer
2024
·
Lyla J. Stanland
, Hazel X. Ang
, et al.
Figure S4 from CBF-beta mitigates PI3K-alpha-specific inhibitor killing through PIM1 in PIK3CA mutant gastric cancer
2024
·
Lyla J. Stanland
, Hazel X. Ang
, et al.
Table S4 from CBF-beta mitigates PI3K-alpha-specific inhibitor killing through PIM1 in PIK3CA mutant gastric cancer
2024
·
Lyla J. Stanland
, Hazel X. Ang
, et al.
Table S8 from CBF-beta mitigates PI3K-alpha-specific inhibitor killing through PIM1 in PIK3CA mutant gastric cancer
2024
·
Lyla J. Stanland
, Hazel X. Ang
, et al.
Figure S5 from CBF-beta mitigates PI3K-alpha-specific inhibitor killing through PIM1 in PIK3CA mutant gastric cancer
2024
·
Lyla J. Stanland
, Hazel X. Ang
, et al.
Table S3 from CBF-beta mitigates PI3K-alpha-specific inhibitor killing through PIM1 in PIK3CA mutant gastric cancer
2024
·
Lyla J. Stanland
, Hazel X. Ang
, et al.
Table S1 from CBF-beta mitigates PI3K-alpha-specific inhibitor killing through PIM1 in PIK3CA mutant gastric cancer
2024
·
Lyla J. Stanland
, Hazel X. Ang
, et al.
Table S9 from CBF-beta mitigates PI3K-alpha-specific inhibitor killing through PIM1 in PIK3CA mutant gastric cancer
2024
·
Lyla J. Stanland
, Hazel X. Ang
, et al.
Table S5 from CBF-beta mitigates PI3K-alpha-specific inhibitor killing through PIM1 in PIK3CA mutant gastric cancer
2024
·
Lyla J. Stanland
, Hazel X. Ang
, et al.
Table S7 from CBF-beta mitigates PI3K-alpha-specific inhibitor killing through PIM1 in PIK3CA mutant gastric cancer
2024
·
Lyla J. Stanland
, Hazel X. Ang
, et al.
Table S2 from CBF-beta mitigates PI3K-alpha-specific inhibitor killing through PIM1 in PIK3CA mutant gastric cancer
2024
·
Lyla J. Stanland
, Hazel X. Ang
, et al.
Supplementary Figure Legends 1-7 from CBF-beta mitigates PI3K-alpha-specific inhibitor killing through PIM1 in PIK3CA mutant gastric cancer
2024
·
Lyla J. Stanland
, Hazel X. Ang
, et al.
Figure S2 from CBF-beta mitigates PI3K-alpha-specific inhibitor killing through PIM1 in PIK3CA mutant gastric cancer
2024
·
Lyla J. Stanland
, Hazel X. Ang
, et al.
Figure S3 from CBF-beta mitigates PI3K-alpha-specific inhibitor killing through PIM1 in PIK3CA mutant gastric cancer
2024
·
Lyla J. Stanland
, Hazel X. Ang
, et al.
Show more works
View as search
Works count:
87
Citation count:
212
H-index:
6
I10-index:
6
Year
Topic
Type
